Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Evista and EstroGel
Link ID 585
Title FDA Safety Changes: Evista and EstroGel
Url http://www.medscape.com/viewarticle/565446?src=rss
Description The FDA has approved revisions to the safety labeling for raloxifene HCl tablets (Evista) and estradiol gel (EstroGel). Medscape Medical News
Category Articles > Cardiology
Keywords
Date Nov 9, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Vitamin D and the Diabetic Patient
  Daniel W. Coyne, MD, Professor of Medicine at Washington University, describes the consequences of low vitamin D and the potential to increase the risk for diabetes mellitus.
Medscape Nephrology
Category:   Articles > Cardiology


2. Potential Chemopreventive Role for Celecoxib in Lung Cancer
  High-dose celecoxib reduced levels of Ki-67, a key biomarker in lung cancer, among patients at high risk for the disease. Medscape Medical News
Category:   Articles > Cardiology


3. ENHANCE Published, Presented, Discussed, and Debated: Experts Mull Over What the Findings Mean
  Plagued by controversy and attracting the watchful eye of congressional committees in the US, ENHANCE stepped into the spotlight at the American College of Cardiology 2008 Scientific Sessions. Not surprisingly, there was no shortage of opinions about what the results mean to clinical practice. Heartwire
Category:   Articles > Cardiology


4. ACUITY One-Year Results Published
  The lead investigator says the one-year results should provide further reassurance on the use of bivalirudin in ACS patients. Heartwire
Category:   Articles > Cardiology


5. The Next Frontier in CV Risk Reduction: Increasing HDL-C in Patients with Mixed Dyslipidemia
  Review the multifaceted role of HDL-based pharmacotherapy to manage dyslipidemia and the benefits of combining new with existing agents to reduce cardiovascular risk.
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS